Alternative splicing of CERS2 promotes cell proliferation and migration in luminal B subtype breast cancer cells

por Pani, Trishna, Rajput, Kajal, Kar, Animesh, Dasgupta, Ujjaini
Publicado 2021

Ceramide Kinase (CERK) Emerges as a Common Therapeutic Target for Triple Positive and Triple Negative Breast Cancer Cells

por Rajput, Kajal, Ansari, Mohammad Nafees, Jha, Somesh K., Pani, Trishna, Medatwal, Nihal, Chattopadhyay, Somdeb, Bajaj, Avinash, Dasgupta, Ujjaini
Publicado 2022

Alternative splicing of ceramide synthase 2 alters levels of specific ceramides and modulates cancer cell proliferation and migration in Luminal B breast cancer subtype

por Pani, Trishna, Rajput, Kajal, Kar, Animesh, Sharma, Harsh, Basak, Rituparna, Medatwal, Nihal, Saha, Sandhini, Dev, Gagan, Kumar, Sharwan, Gupta, Siddhi, Mukhopadhyay, Arnab, Malakar, Dipankar, Maiti, Tushar Kanti, Arimbasseri, Aneeshkumar G., Deo, S. V. S., Sharma, Ravi Datta, Bajaj, Avinash, Dasgupta, Ujjaini
Publicado 2021

A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response

por Kar, Animesh, Jain, Dolly, Kumar, Sandeep, Rajput, Kajal, Pal, Sanjay, Rana, Kajal, Kar, Raunak, Jha, Somesh K., Medatwal, Nihal, Yavvari, Prabhu Srinivas, Pandey, Nishant, Mehta, Devashish, Sharma, Harsh, Bhattacharya, Debanjan, Pradhan, Manas K., Sharma, Ravi Datta, Srivastava, Aasheesh, Agrawal, Usha, Mukhopadhyay, Arnab, Sengupta, Sagar, Patil, Veena S., Bajaj, Avinash, Dasgupta, Ujjaini
Publicado 2023